KCT0003494
Not yet recruiting
未知
A single-center, randomized, double-blind, placebo-controlled human trial to evaluate the effect of steamed Panax Ginseng extract on the improvement of blood glucose level
Dunsan Korean Medicine Hospital of Daejeon University0 sites52 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dunsan Korean Medicine Hospital of Daejeon University
- Enrollment
- 52
- Status
- Not yet recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Adults aged 19 and over
- •2\) If the following criteria apply
- •\- Those who have not taken diabetes treatment
- •\- Fasting venous blood plasma glucose concentration of 100 \~ 125mg / dL
- •\- Those with HbA1C of 5\.7\-6\.4
- •\- Those who fully understand the purpose of this study and agree to participate
Exclusion Criteria
- •1\) patients with type 1 diabetes, gestational diabetes, or type 2 diabetes
- •2\) Those who are taking medication that can have a significant effect on blood glucose control within 1 month
- •3\) Patients with the following underlying diseases: uncontrolled hypertension (systolic blood pressure\> 160 mmHg and diastolic blood pressure\> 100 mmHg even after taking hypertension medication), malignancy, tuberculosis, asthma, glaucoma, depression with psychotic symptoms, bipolar affective disorder , Schizophrenia, dementia, liver function value 3 times or more normal value, renal function 1\.5 times or more in normal range
- •4\) Anyone who is pregnant, is breastfeeding or has a pregnancy plan
- •5\) Daily drinking or smoker more than 1pack per day
- •6\) Those who have an irritable reaction to the test product
- •7\) Those who are at risk of serious drug interactions due to concomitant medication
- •8\) Those who have contraindications for taking medication or medicine mentally
- •9\) Those who can not participate in the legally
- •10\) If there is a possibility of non\-cooperative attitude in this human body test, or if it is judged by the researcher
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Oxytocin TrialAutism Spectrum DisorderMedDRA version: 20.0Level: LLTClassification code 10003805Term: AutismSystem Organ Class: 100000004873Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2013-003067-59-ITAZIENDA OSPEDALIERA G. BROTZ30
Completed
Not Applicable
A single-center, randomized, double-blind, placebo-controlled, parallel-group studie investigating the safety, tolerability and pharmacokinetics of single- and multiple-ascending subcutaneous doses of TA-46 in healthy volunteersAchondroplasiadwarfism10083624NL-OMON48911Therachon SAS102
Recruiting
Not Applicable
A human trial to evaluate effects of ginsenoside fortified red ginseng on immune function and fatigue recoveryNot ApplicableKCT0001647Dunsan Korean Medicine Hospital of Daejeon University52
Completed
Not Applicable
A single-center, randomized, double-blind, placebo-controlled, single ascending dose study to investigate the pharmacokinetics, pharmacodynamic effects, safety and tolerability of single doses of RO5459072 in healthy volunteers.Lupus10003816NL-OMON41854F. Hoffmann-La Roche Ltd.16
Recruiting
Phase 1
A single-center, randomized, double-blind, placebo-controlled, dose escalation study to observe the safety and efficacy of catalpol tablets in Chinese healthy subjects.diabetesITMCTR1900002878The First Affiliated Hospital, Zhejiang University